Table 3.
Priority ranks generated by the scoring system compared with priority ranks generated by experienced breast surgeons
| Priority rank | Patient (system score) | Scoring system | Test patient and tumor characteristics | |||
|---|---|---|---|---|---|---|
| Surgeon 1 | Surgeon 2 | Surgeon 3 | Patient | Score | ||
| 1 | F (18) | H (20) | H (20) | H | 20 | H: 45 yo, 2.5 cm grade 2 IDC, moderate ER+ , PR-, N0 |
| 2 | H (20) | F (18) | F (18) | F | 18 | F: 49 yo, 1.8 cm grade 2 IDC, ER, Oncotype = 25, N0 |
| 3 | G (16) | A (17) | G (16) | A | 17 | A: 49 yo, 1.2 cm grade 2 IDC, strongly ER/PR+ , N0 |
| 4 | I (14) | G (16) | A (17) | G | 16 | G: 68 yo, 1.3 cm grade 3 IDC, strongly ER/PR+ , N0 |
| 5 | A (17) | I (14) | D (13) | I | 14 | I: 55 yo, 0.9 cm grade 2 IDC, ER+ Oncotype = 16, N0 |
| 6 | C (14) | C (14) | I (14) | C | 14 | C: 63 yo, 0.9 cm grade 2 ILC, ER+ Oncotype = 11, N0 |
| 7 | B (12) | D (13) | C (14) | D | 13 | D: 60 yo, 1.4 cm grade 1 DCIS+ mi, strongly ER/PR+ , N0 |
| 8 | D (13) | E (13) | E (13) | E | 13 | E: 62 yo, 1.0 cm grade 2 DCIS, strongly ER + , N0 |
| 9 | E (13) | B (12) | B (12) | B | 12 | B: 90 yo, 1.0 cm grade 1 IDC, strongly ER/PR+ , N0 |
| 10 | J (11) | J (11) | J (11) | J | 11 | J: 79 yo, grade 1 DCIS, strongly ER/PR+ , N0 |
Scores of 18 or higher were considered highest risk, 15–17 considered medium risk, and 14 or lower considered lowest risk
yo years old, ER estrogen receptor, PR progesterone receptor, IDC invasive ductal cancer, DCIS ductal carcinoma in situ; mi: microinvasion, ILC invasive lobular cancer